Guénolé Tossou received his Bachelor's degree through the Magistère de Génétique at Université Paris Cité. His Ph. research focuses on extracellular vesicle biology, regulatory RNAs, and the development of combinatorial RNA therapeutic strategies for aggressive cancers. He is the first author of our recent publication in Molecular Therapy. Guénolé is supported by a doctoral fellowship from the French Ministry of Higher Education and Research (MESR).

Ninon Lippens is currently a student in the Magistère de Génétique at Université Paris Cité. She will join in january 2027 the Jauliac Lab to investigate extracellular vesicle biology, regulatory RNAs, and combinatorial RNA therapeutic strategies for aggressive cancers.

Harris Asare is a Breast Surgery resident and is currently completing his Master's degree (MSc). His research focuses on the development of three-dimensional patient-derived tumor organoid models to study aggressive breast cancers and support the preclinical evaluation of novel RNA-based therapeutic approaches.

Stéphane Brunet is an INSERM Senior Researcher whose research combines cell biology, tissue architecture, and advanced three-dimensional models to better understand cancer biology. In the Jauliac Lab, he develops patient-derived tumor organoid models for translational cancer research.

Laurence Cahen-Doidy is Head of the Breast Surgery Unit at Saint-Louis Hospital (AP-HP) and a clinician-scientist affiliated with INSERM and Université Paris Cité. Her research focuses on translational breast cancer research, with particular interests in precision oncology, predictive biomarkers, and the clinical translation of extracellular vesicle-based approaches.

Lauriane Goldwirt is a Hospital Pharmacist and Head of the Biological Pharmacology Unit at Saint-Louis Hospital (AP-HP). Her expertise in cancer pharmacology, pharmacokinetics, and translational oncology supports the development and preclinical evaluation of innovative therapeutic strategies for cancer.